![]() |
市场调查报告书
商品编码
1830954
内视镜设备市场Endoscopy Device Market |
内视镜设备市场预计将从 2024 年的 348 亿美元扩大到 2031 年的 595.3 亿美元,2025-2031 年期间的预估复合年增长率为 6.9%。
市场洞察与分析师观点:内视镜检查是一种微创手术技术,用于观察人体内部器官,也适用于各种器官的手术。此手术使用称为内视镜的细小柔性管,内视镜配备摄像头,可清晰地显示被检查的器官。根据检查区域的不同,内视镜的类型也有所不同,包括关节镜、支气管镜、腹腔镜和子宫镜。此外,内视镜检查过程中还会使用各种其他设备和仪器,以增强视觉化效果、确保无菌并提高成像品质。
推动成长的因素:微创手术需求不断成长
外科手术中对微创技术的日益青睐,标誌着医疗方法和病患选择的显着转变。这一趋势的动力源于减少手术创伤、降低相关风险和缩短復原时间的目标。内视镜作为一种微创手术方法,切口较小、恢復期较短,并且能够更好地观察体腔内部。外科医生可以使用内视镜观察和操作体内器官,而无需进行大切口手术。微创手术通常切口较小,并使用专门的工具和技术来接触各个器官,从而缩短住院时间并减少疤痕。此外,患者通常疼痛程度较低,能够更快恢復正常活动。外科医生之所以采用这些技术,是因为它们的优势,以及医疗设备和外科手术技术的进步。因此,医疗机构正在投资培训医护人员併购置必要的设备,以满足日益增长的微创内视镜手术需求,从而增强治疗选择并提升患者的整体医疗体验。
战略洞察
报告细分和范围:「内视镜设备市场」根据产品、应用和最终用户进行分类。就产品而言,市场分为内视镜、视觉化系统、配件和其他内视镜设备。内视镜细分市场进一步分为柔性内视镜、刚性内视镜、机器人辅助内视镜和胶囊内视镜。可视化系统细分市场进一步分为无线显示器和监视器、光源、视讯处理器、内视镜摄影机、录影机、视讯转换器、推车、发射器和接收器、摄影机和其他仪器。其他内视镜设备细分市场包括电子和机械仪器。配件细分市场细分为清洁刷、外套管、手术解剖器、光纤电缆、液体冲洗装置、持针器/针钳、咬嘴、切片阀等。根据应用,内视镜设备市场可细分为胃镜、腹腔镜、关节镜、耳镜、泌尿内视镜、支气管镜、喉镜和其他应用。此外,市场还根据最终用户细分为医院、门诊手术中心和其他。
細項分析:就产品而言,内视镜在2022年占据了内视镜设备市场的最大份额。可视化系统预计将在2022-2030年期间呈现最高的复合年增长率。内视镜检查过程中使用的可视化系统对于捕捉高品质的影像和视讯至关重要。此细分市场包括无线显示器和监视器、光源、视讯处理器、内视镜摄影机、录影机、视讯转换器、推车、发射器和接收器、摄影机以及其他仪器等组件。波士顿科学公司和卡尔史托斯股份公司等公司是内视镜设备市场视觉化系统的主要供应商。
在应用方面,胃镜检查在2022年占据了内视镜设备市场的最大份额,而腹腔镜检查预计将在2022-2030年期间呈现最高的复合年增长率。胃镜检查,也称为上消化道内视镜检查,涉及检查上消化道,包括食道、胃和十二指肠(小肠的起始部分)。它用于诊断溃疡、肿瘤、发炎和胃食道逆流(GERD)等疾病。专为胃镜设计的内视镜设备采用配备先进成像功能的柔性内视镜,包括高清摄影机和光学增强功能。
按最终用户划分,医院在 2022 年占据了内视镜设备市场的最大份额,预计在 2022-2030 年期间的复合年增长率最高。医院涵盖了从社区医院到大型学术医疗中心等各种医疗机构,是内视镜设备的重要最终用户。医院对内视镜设备的需求主要源于患者数量的增长,这归因于全面的医疗服务、住院和门诊服务以及先进的手术。医院配备了执行复杂内视镜检查的设备,包括外科手术、高阶影像和专门的治疗性内视镜检查。内视镜也用于检查体内空腔器官或腔体的内部。某些内视镜检查,例如膀胱镜检查,通常在医院门诊进行,而用于治疗或移除肾结石的输尿管镜检查则在手术室进行。同样,大多数耳鼻喉内视镜检查(例如评估患者鼻子或喉咙的呼吸或吞嚥问题)都是在住院和门诊医院环境中进行的。
区域分析:从地理来看,内视镜设备市场分为亚太地区、欧洲、中东和非洲、北美以及南美和中美。 2022年,北美占据全球市场最大份额,而预计2022年至2030年期间,亚太地区内视镜设备市场的复合年增长率最高。
北美内视镜设备市场由美国、加拿大和墨西哥组成,其中美国是该地区最大的市场。市场成长主要得益于人们对微创手术的日益青睐以及癌症发生率的上升。其他推动市场扩张的因素包括先进医疗设备的引入、医院数量的增加以及政府策略政策的实施。此外,由于患者人数不断增长和医疗资源有限,对自动化系统的需求预计将推动美国内视镜系统的普及。在预测期内,配备高清摄影机和光源的先进内视镜设备的使用预计将显着推动市场成长。
内视镜设备市场报告范围
产业发展与未来机会:内视镜设备市场主要参与者采取的关键措施包括:
2023年2月,波士顿科学公司宣布其LithoVue Elite一次性电子柔性输尿管镜系统获得FDA批准,这是首款能够在输尿管镜检查过程中即时监测肾内压力的输尿管镜。该系统包含StoneSmart Connect控制台,可增强影像品质、控制功能和整合度。 2023年9月,Ambu扩大了其胃肠病学产品组合,推出了Ambu aScope Gastro Large和Ambu aBox 2,这两款新型大型胃镜解决方案即将在欧洲上市。 Ambu aScope Gastro Large是全球首款配备4.2毫米操作通道的胃镜,可在ICU和内视镜科室的手术过程中提供卓越的吸力性能,同时也是首款采用生物塑料材料製成的内视镜。
2022年9月,美敦力公司宣布,Nexpowder内视镜止血系统获得美国食品药物管理局(FDA)批准。该系统由美敦力公司在全球经销,由韩国NEXTBIOMEDICAL有限公司开发。本系统采用专利粉末涂层技术的导管,喷洒非接触、无热、无创伤的止血粉末。
2023年9月,史赛克公司推出了新一代微创手术摄影系统-1,788平台。此摄影平台采用升级技术,可用于多个专业的进阶手术,提供色彩鲜艳的影像和均衡的照明,增强血流和关键解剖结构的可视化,并可同时显示多种光学成像剂。竞争格局与主要公司:内视镜设备市场的知名公司包括波士顿科学公司、美敦力公司、史赛克公司、强生公司、Karl Storz SE & Co KG、奥林巴斯公司、Ambu AS、Conmed Corp、B Braun SE 和宾得医疗。这些公司专注于开发新技术、改进现有产品并拓展地理范围,以满足日益增长的全球消费者需求。
The Endoscopy Device market is anticipated to expand from US$ 34.80 billion in 2024 to US$ 59.53 billion by 2031, with a projected CAGR of 6.9% during the period of 2025-2031.
Market Insights and Analyst Perspective:Endoscopy is a minimally invasive surgical technique used to visualize the internal organs of the human body and is also applicable in surgeries on various organs. This procedure utilizes a small flexible tube called an endoscope, which is equipped with a camera to provide a clear view of the organ being examined. Depending on the area of interest, different types of scopes are available, including arthroscopes, bronchoscopes, laparoscopes, and hysteroscopes. Additionally, various other devices and instruments are utilized during endoscopy to enhance visualization, ensure sterilization, and improve imaging quality.
Factors Driving Growth:Rising Demand for Minimally Invasive Procedures
The increasing preference for minimally invasive techniques in surgical practices signifies a notable transformation in medical approaches and patient choices. This trend is fueled by the aim to reduce the invasiveness of procedures, lower associated risks, and facilitate quicker recovery times. Endoscopy, as a minimally invasive surgical method, involves smaller incisions, shorter recovery periods, and improved visibility into the internal body cavity. Surgeons can visualize and operate within the body using an endoscope without the need for large incisions. Minimally invasive methods generally involve smaller cuts and the use of specialized tools and technologies to access various organs, resulting in shorter hospital stays and reduced scarring. Furthermore, patients typically experience less pain and a faster return to their normal activities. Surgeons are adopting these techniques due to their advantages, alongside advancements in medical devices and surgical expertise. Consequently, healthcare institutions are investing in training their medical personnel and acquiring the necessary equipment to cater to the rising demand for minimally invasive endoscopy surgeries, thus enhancing treatment options and overall healthcare experiences for patients.
Strategic Insights
Report Segmentation and Scope:The "endoscopy device market" is categorized based on product, application, and end user. In terms of product, the market is divided into endoscopes, visualization systems, accessories, and other endoscopy devices. The endoscopes segment is further divided into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and capsule endoscopes. The visualization systems segment is further categorized into wireless displays and monitors, light sources, video processors, endoscopic cameras, video recorders, video converters, carts, transmitters and receivers, camera heads, and other instruments. The other endoscopy devices segment includes electronic and mechanical instruments. The accessories segment is subdivided into cleaning brushes, overtubes, surgical dissectors, light cables, fluid flushing devices, needle holders/needle forceps, mouthpieces, biopsy valves, and others. By application, the endoscopy device market is segmented into gastroscopy, laparoscopy, arthroscopy, otoscopy, urology endoscopy, bronchoscopy, laryngoscopy, and other applications. The market is also segmented by end user into hospitals, ambulatory surgical centers, and others.
Segmental Analysis:In terms of product, the endoscopes segment accounted for the largest share of the endoscopy device market in 2022. The visualization systems segment is projected to exhibit the highest CAGR during 2022-2030. Visualization systems utilized in endoscopy procedures are essential for capturing high-quality images and videos. This segment includes components such as wireless displays and monitors, light sources, video processors, endoscopic cameras, video recorders, video converters, carts, transmitters and receivers, camera heads, and other instruments. Companies like Boston Scientific Corporation and KARL STORZ SE & Co. KG are key providers of visualization systems in the endoscopy device market.
Regarding application, the gastroscopy segment held the largest share of the endoscopy device market in 2022, while the laparoscopy segment is expected to show the highest CAGR during 2022-2030. Gastroscopy, also referred to as upper endoscopy, involves examining the upper gastrointestinal tract, including the esophagus, stomach, and duodenum (the initial part of the small intestine). It is utilized to diagnose conditions such as ulcers, tumors, inflammation, and gastroesophageal reflux disease (GERD). Endoscopy devices designed for gastroscopy feature flexible endoscopes equipped with advanced imaging capabilities, including high-definition cameras and optical enhancements.
By end user, the hospitals segment represented the largest share of the endoscopy device market in 2022 and is expected to register the highest CAGR during 2022-2030. Hospitals encompass a wide range of medical facilities, from community hospitals to large academic medical centers, and are significant end users of endoscopy devices. The demand for endoscopy devices in hospitals is primarily driven by a high volume of patients, attributed to comprehensive care delivery, inpatient and outpatient services, and advanced procedures. Hospitals are equipped to perform complex endoscopic procedures, including surgeries, advanced imaging, and specialized therapeutic endoscopy. Endoscopes are also employed to examine the interiors of hollow organs or cavities within the body. Certain endoscopic examinations, such as cystoscopies, are typically conducted in hospital outpatient settings, while ureteroscopy procedures for managing or removing kidney stones are performed in operating rooms. Similarly, most ENT endoscopies, such as those assessing a patient's nose or throat for breathing or swallowing issues, are carried out in both inpatient and outpatient hospital environments.
Regional Analysis:Geographically, the endoscopy device market is divided into Asia Pacific, Europe, the Middle East & Africa, North America, and South & Central America. In 2022, North America held the largest share of the global market, while Asia Pacific is expected to exhibit the highest CAGR in the endoscopy device market from 2022 to 2030.
The North American endoscopy device market is comprised of the US, Canada, and Mexico, with the US being the largest market in this region. The market growth is primarily driven by the increasing preference for minimally invasive surgeries and the rising prevalence of cancer. Additional factors contributing to market expansion include the introduction of advanced healthcare equipment, a higher number of hospitals, and the implementation of strategic government policies. Furthermore, the demand for automated systems due to the growing patient population and limited healthcare resources is anticipated to boost the adoption of endoscopy systems in the US. The emphasis on utilizing technologically advanced endoscopy devices equipped with high-definition cameras and light sources is also expected to significantly drive market growth during the forecast period.
Endoscopy Device Market Report Scope
Industry Developments and Future Opportunities:Key initiatives undertaken by major players in the endoscopy device market include:
In February 2023, Boston Scientific Corp announced FDA approval for its LithoVue Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope capable of monitoring intrarenal pressure in real-time during ureteroscopy procedures. This system includes the StoneSmart Connect Console, which enhances image quality, control features, and integration.In September 2023, Ambu expanded its gastroenterology portfolio with the introduction of the Ambu aScope Gastro Large and Ambu aBox 2, two new larger-sized gastroscopy solutions set to launch in Europe. The Ambu aScope Gastro Large is notable for being the first gastroscope globally with a 4.2 mm operating channel, allowing for superior suction performance during procedures in the ICU and endoscopy unit, and is also the first endoscope made from bioplastic materials.
In September 2022, Medtronic plc announced FDA approval for the Nexpowder endoscopic hemostasis system, which is distributed globally by Medtronic and developed by NEXTBIOMEDICAL CO., LTD (Korea). This system utilizes a catheter with patented powder-coating technology to spray a noncontact, nonthermal, and nontraumatic hemostatic powder.
In September 2023, Stryker Corp launched the 1788 platform, a next-generation minimally invasive surgical camera system. This camera platform features upgraded technology for use in advanced surgeries across multiple specialties, providing vibrant images with balanced lighting to enhance visualization of blood flow and critical anatomy, and can visualize multiple optical imaging agents.Competitive Landscape and Key Companies:Prominent companies in the endoscopy device market include Boston Scientific Corp, Medtronic Plc, Stryker Corp, Johnson & Johnson, Karl Storz SE & Co KG, Olympus Corp, Ambu AS, Conmed Corp, B Braun SE, and PENTAX Medical. These companies are focused on developing new technologies, enhancing existing products, and expanding geographically to meet the growing global consumer demand.